ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
ONCOLYTICS BIOTECH INC
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Aug 12, 2026
$0.50−0.00 (-0.36%)
Close on Oct 19, 2026
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
3.1%
4M of 128M shares
Institutional holders
75
74 new, 1 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
14 buys · 0 sales
Net bought $363.23K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Anson Funds Management LP | 7,649,050 | 7.00% | 13G (passive) amendment | Sep 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ONCY | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Marshall Wace, Llp | 745,350 | 0.58% | $708.08K | −114,481 | 0.00% |
| XTX Topco Ltd | 260,903 | 0.20% | $247.83K | New | 0.00% |
| Seeds Investor LLC | 258,306 | 0.20% | $245.37K | New | 0.03% |
| International Assets Investment Management, LLC | 201,260 | 0.16% | $181.28K | New | 0.01% |
| Connective Capital Management, LLC | 185,712 | 0.15% | $176.41K | New | 0.12% |
| Goldman Sachs Group Inc | 169,898 | 0.13% | $161.39K | New | 0.00% |
| Tocqueville Asset Management L.P. | 147,000 | 0.12% | $139.64K | New | 0.00% |
| Everhart Financial Group, Inc. | 140,899 | 0.11% | $133.84K | New | 0.01% |
| Susquehanna International Group, Llp | 134,129 | 0.11% | $127.41K | New | 0.00% |
| PFG Investments, LLC | 128,300 | 0.10% | $121.87K | New | 0.00% |
| Hrt Financial LP | 126,325 | 0.10% | $119 | New | 0.00% |
| Invesco Ltd. | 101,195 | 0.08% | $96.13K | New | 0.00% |
| Doliver Advisors, LP | 100,000 | 0.08% | $94.99K | New | 0.02% |
| LPL Financial LLC | 80,316 | 0.06% | $76.29K | New | 0.00% |
| Franklin Resources Inc | 79,842 | 0.06% | $75.84K | New | 0.00% |
| Cibc World Market Inc. | 69,303 | 0.05% | $65.83K | New | 0.00% |
| Geode Capital Management, LLC | 66,939 | 0.05% | $63.59K | New | 0.00% |
| Renaissance Technologies LLC | 62,010 | 0.05% | $58.90K | New | 0.00% |
| Royal Bank of Canada | 57,411 | 0.05% | $55.00K | New | 0.00% |
| Fifth Third Bancorp | 45,526 | 0.04% | $43.25K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 75 | 4M | 3.1% | 74 / 0 | 1 / 1 | 3M | 0M |
| Q1 2026 | 2 | 1M | 0.7% | 2 / 0 | 0 / 0 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ONCY | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund | 66,939 | 0.05% | $69.62K | 0.00% | May 31, 2026 |
| Victory Extended Market Index Fund | 13,506 | 0.01% | $10.17K | 0.00% | Jul 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -1,300 | -0.00% | -$1.23K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jared Kelly | Chief Executive Officer, Director | 114,050 | 0.09% | Jun 3, 2026 |
| John Bearden McAdory | Chief Operating Officer | – | – | Jun 3, 2026 |
| Kirk Look | Chief Financial Officer | 287,515 | 0.23% | Jun 3, 2026 |
| Allison Hagerman | Chief Technology Officer | 115,059 | 0.09% | Jun 3, 2026 |
| Thomas Charles Heineman | Chief Medical Officer | 282,818 | 0.22% | Jun 3, 2026 |
| Andrew Aromando | Chief Business Officer | 55,100 | 0.04% | Jun 3, 2026 |
| Deborah Margaret Brown | Director | 109,851 | 0.09% | Jun 3, 2026 |
| Stephen C. Glover | Director | – | – | Jun 3, 2026 |
| Angela Holtham | Director | 183,639 | 0.14% | Jun 3, 2026 |
| Jonathan Rigby | Director | 42,728 | 0.03% | Jun 3, 2026 |
| Wayne Pisano | Director | 492,414 | 0.39% | Jun 3, 2026 |
| James T. Parsons | Director | 41,849 | 0.03% | Jun 3, 2026 |
| Bernd R. Seizinger | Director | 566,991 | 0.44% | Jun 3, 2026 |
| Patricia S. Andrews | Director | 78,128 | 0.06% | Jun 3, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jared Kelly Chief Executive Officer, Director | Mar 12, 2026 | Buy | +5,050 | $0.96 | $4.85K | 114,050 |
| James T. Parsons Director | Mar 11, 2026 | Buy | +10,000 | $1.03 | $10.30K | 41,849 |
| Thomas Charles Heineman Chief Medical Officer | Feb 12, 2026 | Buy | +12,132 | $0.83 | $10.07K | 282,818 |
| Wayne Pisano Director | Feb 12, 2026 | Buy | +30,000 | $0.84 | $25.20K | 492,414 |
| Allison Hagerman VP, Product Development | Feb 12, 2026 | Buy | +10,000 | $0.83 | $8.30K | 115,059 |
| Bernd R. Seizinger Director | Feb 12, 2026 | Buy | +40,000 | $0.85 | $34.00K | 566,991 |
| Jared Kelly Chief Executive Officer, Director | Feb 12, 2026 | Buy | +29,500 | $0.84 | $24.78K | 109,000 |
| Patricia S. Andrews Director | Feb 12, 2026 | Buy | +35,400 | $0.86 | $30.44K | 78,128 |
| Kirk Look Chief Financial Officer | Feb 12, 2026 | Buy | +12,000 | $0.84 | $10.08K | 287,515 |
| Deborah Margaret Brown Director | Feb 12, 2026 | Buy | +25,000 | $0.85 | $21.25K | 109,851 |
| Andrew Aromando Chief Business Officer | Feb 11, 2026 | Buy | +29,600 | $0.86 | $25.46K | 55,100 |
| Bernd R. Seizinger Director | Feb 11, 2026 | Buy | +60,000 | $0.83 | $49.80K | 526,991 |
| Jared Kelly Chief Executive Officer, Director | Feb 11, 2026 | Buy | +5,600 | $0.84 | $4.70K | 79,500 |
| Bernd R. Seizinger Director | Jan 16, 2026 | Buy | +100,000 | $1.04 | $104.00K | 466,991 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.